Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Emily C Zabor

Showing results (21-30 of 167) with videos related to

Pageof 17
Sort By:
The British Journal of Ophthalmology|June 20, 2025
Intra-arterial chemotherapy for retinoblastoma: a performance analysisYehonatan Weinberger, Saloni Kapoor, Emily C Zabor, et al.
The British Journal of Ophthalmology|April 12, 2024
Predictive model for iris melanomaArun Singh, Alexander Melendez-Moreno, Jørgen Krohn, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 23, 2015
Correlating Surrogate Endpoints with Overall Survival at the Individual Patient Level in BRAFV600E-Mutated Metastatic Melanoma Patients Treated with VemurafenibEmily C Zabor, Glenn Heller, Lawrence H Schwartz, et al.
Ophthalmology|March 21, 2025
Surveillance for Metastasis in Low-Risk Uveal Melanoma Patients: The Need for OptimizationAdrienne Delaney, Yağmur Seda Yeşiltaş, Emily C Zabor, et al.
Cancer|August 6, 2013
Dynamic prognostication using conditional survival estimatesEmily C Zabor, Mithat Gonen, Paul B Chapman, et al.
International Journal of Radiation Oncology, Biology, Physics|August 20, 2021
Logistic Regression in Clinical StudiesEmily C Zabor, Chandana A Reddy, Rahul D Tendulkar, et al.
Taiwan Journal of Ophthalmology|April 11, 2025
Growth of indeterminate choroidal melanocytic tumors: Time to malignant transformationZackery Oakey, Yağmur Seda Yeşiltaş, Emily C Zabor, et al.
Statistical Methods in Medical Research|July 28, 2021
Validity of a method for identifying disease subtypes that are etiologically heterogeneousEmily C Zabor, Venkatraman E Seshan, Shuang Wang, et al.
Frontiers in Oncology|December 23, 2022
Optimal predictive probability designs for randomized biomarker-guided oncology trialsEmily C Zabor, Alexander M Kaizer, Nathan A Pennell, et al.
Hypertension (Dallas, Tex. : 1979)|July 26, 2017
Hypertension and VEGF (Vascular Endothelial Growth Factor) Receptor Tyrosine Kinase Inhibition: Effects on Renal FunctionBrian C Boursiquot, Emily C Zabor, Ilya G Glezerman, et al.
Pageof 17

Showing results (21-30 of 167) with videos related to

Sort By:
Pageof 17
The British Journal of Ophthalmology|June 20, 2025
Intra-arterial chemotherapy for retinoblastoma: a performance analysisYehonatan Weinberger, Saloni Kapoor, Emily C Zabor, et al.
The British Journal of Ophthalmology|April 12, 2024
Predictive model for iris melanomaArun Singh, Alexander Melendez-Moreno, Jørgen Krohn, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 23, 2015
Correlating Surrogate Endpoints with Overall Survival at the Individual Patient Level in BRAFV600E-Mutated Metastatic Melanoma Patients Treated with VemurafenibEmily C Zabor, Glenn Heller, Lawrence H Schwartz, et al.
Ophthalmology|March 21, 2025
Surveillance for Metastasis in Low-Risk Uveal Melanoma Patients: The Need for OptimizationAdrienne Delaney, Yağmur Seda Yeşiltaş, Emily C Zabor, et al.
Cancer|August 6, 2013
Dynamic prognostication using conditional survival estimatesEmily C Zabor, Mithat Gonen, Paul B Chapman, et al.
International Journal of Radiation Oncology, Biology, Physics|August 20, 2021
Logistic Regression in Clinical StudiesEmily C Zabor, Chandana A Reddy, Rahul D Tendulkar, et al.
Taiwan Journal of Ophthalmology|April 11, 2025
Growth of indeterminate choroidal melanocytic tumors: Time to malignant transformationZackery Oakey, Yağmur Seda Yeşiltaş, Emily C Zabor, et al.
Statistical Methods in Medical Research|July 28, 2021
Validity of a method for identifying disease subtypes that are etiologically heterogeneousEmily C Zabor, Venkatraman E Seshan, Shuang Wang, et al.
Frontiers in Oncology|December 23, 2022
Optimal predictive probability designs for randomized biomarker-guided oncology trialsEmily C Zabor, Alexander M Kaizer, Nathan A Pennell, et al.
Hypertension (Dallas, Tex. : 1979)|July 26, 2017
Hypertension and VEGF (Vascular Endothelial Growth Factor) Receptor Tyrosine Kinase Inhibition: Effects on Renal FunctionBrian C Boursiquot, Emily C Zabor, Ilya G Glezerman, et al.
Pageof 17